I-129V

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameI-129V
Drug Alias NameI129V
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon beta stimulants
TargetsInterferon beta
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenencor International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenencor International Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A